29. Fischer H, Koenig U, Eckhart L, Tschachler E (2002) Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 293: 722–726. 30. Robertson JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S (2002) Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 277: 29803–29809. 31. Cheung HH, Lynn Kelly N, Liston P, Korneluk RG (2006) Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp Cell Res 312: 2347–2357. 32. Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7: 880–885. 33. Wang KK (2000) Calpain and caspase: can you tell the difference?, by kevin K.W. WangVol. 23, 20–26. Trends Neurosci 23: 59. 34. Martin SJ, O’Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, et al. (1995) Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 270: 6425–6428. 35. Shackleton GL, Gibson GG, Sharma RK, Howes D, Orrenius S, et al. (1995) Diverse mechanisms of calcium mobilization by peroxisome proliferators in rat hepatocytes. Toxicol Appl Pharmacol 130: 294–303. 36. Elrod HA, Sun SY (2008) PPARgamma and Apoptosis in Cancer. PPAR Res 2008: 704165. 37. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, et al. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid- beta. Nature 403: 98–103. 38. Eizirik DL, Cardozo AK, Cnop M (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29: 42–61. 39. Troy CM, Ribe EM (2008) Caspase-2: vestigial remnant or master regulator? Sci Signal 1: pe42. 40. de Figueiredo P, Brown WJ (1999) Clofibrate inhibits membrane trafficking to the Golgi complex and induces its retrograde movement to the endoplasmic reticulum. Cell Biol Toxicol 15: 311–323. 41. Nakamura M, Kuroiwa N, Kono Y, Takatsuki A (2001) Characterization of clofibrate-induced retrograde Golgi membrane movement to the endoplasmic reticulum: clofibrate distinguishes the Golgi from the trans Golgi network. Biosci Biotechnol Biochem 65: 1812–1823. 42. Nakagawa T, Yuan J (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150: 887–894. 43. Varghese J, Radhika G, Sarin A (2001) The role of calpain in caspase activation during etoposide induced apoptosis in T cells. Eur J Immunol 31: 2035–2041. Rapid Jurkat Apoptosis by Clofibrate 44. Del Bello B, Moretti D, Gamberucci A, Maellaro E (2007) Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status. Oncogene 26: 2717–2726. 45. Kim KA, Lee YA, Shin MH (2007) Calpain-dependent calpastatin cleavage regulates caspase-3 activation during apoptosis of Jurkat T cells induced by Entamoeba histolytica. Int J Parasitol 37: 1209–1219. 46. Fanelli C, Coppola S, Barone R, Colussi C, Gualandi G, et al. (1999) Magnetic fields increase cell survival by inhibiting apoptosis via modulation of Ca2+ influx. FASEB J 13: 95–102. 47. Oh-hora M, Rao A (2008) Calcium signaling in lymphocytes. Curr Opin Immunol 20: 250–258. 48. Dorio A, Cerella C, De Nicola M, D’Alessio M, Gualandi G, et al. (2007) Non- apoptogenic Ca2+-related extrusion of mitochondria in anoxia/reoxygenation stress. Ann N Y Acad Sci 1099: 512–515. 49. Hayden RE, Pratt G, Davies NJ, Khanim FL, Birtwistle J, et al. (2009) Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40- ligand, in part through increased 15dDelta12,14,PGJ2. Leukemia 23: 292–304. 50. Fenton SL, Luong QT, Sarafeim A, Mustard KJ, Pound J, et al. (2003) Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt’s lymphoma cells and cell lines: potential for applying old drugs to a new disease. Leukemia 17: 568–575. 51. Nilsson A, Farrants AK, Nesland JM, Finstad HS, Pedersen JI (1995) Potentiating effects of clofibric acid on the differentiation of HL-60 human promyelocytic leukemia cells induced by retinoids. Eur J Cell Biol 67: 379–385. 52. Fenton SL, Drayson MT, Hewison M, Vickers E, Brown G, et al. (1999) Clofibric acid: a potential therapeutic agent in AML and MDS. Br J Haematol 105: 448–451. 53. Scatena R, Nocca G, Sole PD, Rumi C, Puggioni P, et al. (1999) Bezafibrate as differentiating factor of human myeloid leukemia cells. Cell Death Differ 6: 781– 787. 54. Khanim FL, Hayden RE, Birtwistle J, Lodi A, Tiziani S, et al. (2009) Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. PLoS One 4: e8147. 55. Murray JA, Khanim FL, Hayden RE, Craddock CF, Holyoake TL, et al. (2010) Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML). Br J Haematol 149: 65–69. PLOS ONE | www.plosone.org 11 September 2012 | Volume 7 | Issue 9 | e45327